Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.
ncRNA name
CircARVCF
Specific or universal ncRNAs
Specific ncRNAs
Class
Circular RNA
Biomarker
None
Biomarker application
Upstream regulatory factors
Not available
Downstream target
miR-1205/FGFR1
Cancer name
Gastric Cancer
Cancer site
qRT-PCR,Western blot,Dual-luciferase assay
Treatment type
Chemotherapy
Drug
Cisplatin
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
20
Male patients
17
Female patients
25-71
Age range and number
Not available
PMID
Description
CircARVCF Contributes to Cisplatin Resistance in Gastric Cancer by Altering miR-1205 and FGFR1
Tissue resource
gastric cancer and matched adjacent non-tumor tissues
human normal gastric mucosa cell lines GES-1
gastric cancer cell lines N87
gastric cancer cell lines HGC-27
gastric cancer cell lines MKN-45
gastric cancer cell lines AGS
Experiment
37
Institute
Huai'an First People's hospital
Procell
Country
China
China
Continent
Asia
Asia
Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.